Aortic Stent Grafts Market Is Set To Expand Significantly In Terms Of Revenue And CAGR By 2030

 What Market Size Is Projected For The Aortic Stent Grafts Market By 2030?

The aortic stent grafts market size has grown strongly in recent years. It will grow from $3.59 billion in 2025 to $3.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rising prevalence of abdominal and thoracic aortic aneurysms, early adoption of evar and tevar procedures, growth in vascular surgery infrastructure, increasing availability of endovascular device technologies, growing geriatric population with cardiovascular risk.

The aortic stent grafts market size is expected to see strong growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing procedural volumes in ambulatory and outpatient surgical centers, rising demand for hybrid and advanced stent graft systems, expansion of screening programs for aortic aneurysm detection, growing investments in minimally invasive vascular therapy, increasing focus on reducing postoperative complications and hospital stay. Major trends in the forecast period include increasing preference for minimally invasive endovascular repair over open aortic surgery, growing clinical adoption of modular and customizable aortic stent graft designs, rising demand for next-generation graft materials offering greater flexibility and durability, expanding utilization of stent grafts in complex abdominal and thoracic aneurysm cases, increasing shift toward early aneurysm intervention to reduce rupture risk.

Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17062&type=smp

What Are The Main Market Drivers Shaping The Progression Of The Aortic Stent Grafts Market?
The rise in cardiovascular diseases propels the growth of the aortic stent graft market going forward. The increase in cardiovascular disease cases is primarily due to lifestyle factors such as poor diet, lack of exercise, smoking, and rising obesity rates. Aortic stent grafts are used in cardiovascular disease to repair and reinforce weakened or damaged sections of the aorta, particularly in cases of aneurysms. For instance, in January 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, coronary heart disease (CHD) was a major cause of mortality in the UK, responsible for approximately 68,000 deaths annually. This translates to an average of 190 deaths per day, or one death roughly every eight minutes. In the UK, coronary heart disease accounts for the deaths of one in eight men and one in 14 women. Therefore, the rise in cardiovascular diseases is driving the growth of the aortic stent graft market.

What Leading Segment Types Are Used To Analyze The Aortic Stent Grafts Market?
The aortic stent grafts market covered in this report is segmented –

1) By Product: Abdominal Aortic Stents Graft, Thoracic Aortic Stents Graft
2) By Indication: Abdominal Aortic Aneurysms, Thoracic Aortic Aneurysms
3) By End User: Hospitals, Ambulatory Surgical Centers Or Outpatient Surgical Centers, Other End-Users

Subsegments:
1) By Abdominal Aortic Stent Graft: Endovascular Aneurysm Repair (EVAR) Stent Grafts, Aortic Aneurysm Stent Grafts
2) By Thoracic Aortic Stent Graft: Thoracic Endovascular Aortic Repair (TEVAR) Stent Grafts, Hybrid Aortic Stent Grafts

Which Trends Are Currently Influencing The Direction Of The Aortic Stent Grafts Market?
Major companies operating in the aortic stent graft market are focused on developing advanced products, such as stent-graft system with improved stability, flexibility, and reduced complication risks. A stent-graft system refers to a medical device used in endovascular procedures to treat aneurysms, consisting of a stent for support and a graft to reinforce the vessel wall. For instance, in August 2024, Terumo India, an India-based medical device company, launched TREO Abdominal Stent-graft system. The TREO Abdominal Stent-Graft System is an advanced endovascular device designed for treating infrarenal abdominal aortic aneurysms, offering features like in situ limb adjustability, enhanced sealing, and robust fixation for improved stability and long-term patient outcomes.

Who Are The Core Market Contributors Recognized Within The Aortic Stent Grafts Market Ecosystem?
Major companies operating in the aortic stent grafts market are Medtronic plc, W.L. Gore & Associates Inc, Terumo Corporation, Cook Medical Inc, Endologix Inc, Lombard Medical Ltd, MicroPort Scientific Corporation, Jotec GmbH, Braile Biomédica, Merit Medical Systems Inc, Endospan Ltd, Lifetech Scientific (Shenzhen) Co Ltd, Biomerics LLC, Bentley InnoMed GmbH, Trivascular Inc, Abbott Laboratories, Becton Dickinson and Company, Biotronik SE & Co KG, Altura Medical Inc, S&G Biotech Inc

Get Your In-Depth Aortic Stent Grafts Market Report Now:
https://www.thebusinessresearchcompany.com/report/aortic-stent-grafts-global-market-report

Which Locations Are Showing Rapid Adoption And Strong Growth Indicators In The Aortic Stent Grafts Market?
North America was the largest region in the aortic stent grafts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn